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Abstract
Background: β-hydroxy-β-methylbutyric acid (HMB) is an interesting supplement in sports. However, literature
sources present a limited number of studies that verify the efficacy of HMB intake over a longer time period among
endurance athletes. For this reason, the aim of this study was to assess the effect of HMB supplementation on
physical capacity, body composition and levels of biochemical markers in rowers.
Methods: Sixteen elite male rowers were administered a 12-week HMB supplementation (3×1 gHMB · day
−1) and
placebo administration (PLA) following the model of a randomised, placebo controlled, double-blind crossover
study with a 10 days washout period. Over the course of the experiment, aerobic (maximal oxygen uptake,
ventilatory threshold) and anaerobic (anaerobic power indices) capacity were determined, while analyses were
conducted on body composition as well as levels of creatine kinase, lactate dehydrogenase, testosterone, cortisol
and the T/C ratio. A normal distribution of variables was tested using the paired 2-tailed t-tests; the Mann–Whitney
U-test or the Wilcoxon-signed rank test were applied for non-normally distributed variables.
Results: Following HMB supplementation, _VO2 max increased (+2.7 mL · min
−1 · kg−1) significantly (p < 0.001) in
comparison to its reduction after PLA (−1.0 mL · min−1 · kg−1). In turn, at the ventilatory threshold, a longer time
was required to reach this point (+1.2 minHMB vs. −0.2 minPLA, p = 0.012), while threshold load (+0.42 W · kg
−1
HMB vs.
−0.06 W · kg−1PLA, p = 0.002) and threshold heart rate (+9 bpmHMB vs. +1 bpmPLA, p < 0.001) increased. After HMB
supplementation, fat mass decreased (−0.9 kgHMB vs. +0.8 kgPLA, p = 0.03). In relation to the initial values after HMB
supplementation, the refusal time to continue in the progressive test was extended (p = 0.04), maximum load (p = 0.04)
and anaerobic peak power (p = 0.02) increased. However, in relation to the placebo, no differences were observed in
anaerobic adaptation or blood marker levels.
Conclusions: The results indicate that HMB intake in endurance training has an advantageous effect on the increase in
aerobic capacity and the reduction of fat mass. It may also stimulate an increase in peak anaerobic power, while it seems
to have no effect on other indices of anaerobic adaptation and levels of investigated markers in the blood.
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Background
β-hydroxy-β-methylbutyric acid (HMB) – a metabolite
of leucine and 2-ketoisocaproic acid – has, for almost
20 years, drawn special attention regarding supplemen-
tation support in sports [1–5]. A major advantage of its
use suggested in the literature is connected with its
anticatabolic action, manifested particularly when there
is a high load on the body and when muscle damage is
experienced, which may result from the potential effect
of HMB on the enhancement of the synthesis or the
inhibition of the proteolysis of muscle proteins [2, 5–7].
The observed effect of HMB on the reduction of body
mass loss, muscle mass loss, and the degree of cancerous
cachexia, as well as slowed neoplasm proliferation, should
also be mentioned here [8, 9]. These beneficial effects
might be connected with the influence of HMB on the
de novo synthesis of cholesterol [5, 7, 10], the expres-
sion of insulin-like growth factor 1 (IGF-1) [11, 12], the
stimulation of the mTOR kinase pathway [6, 8, 12, 13]
or the ubiquitin-proteasome system and caspase activ-
ity [7, 9, 14–16]. The possible impact of HMB on the
activation of AMPK kinase and Sirt 1, may promote
stimulation of mitochondrial biogenesis, higher oxy-
gen consumption, increased efficiency of carbohydrate
and fat metabolism, increased lipolysis and fat mass
reduction [17, 18].
Studies assessing the effects of HMB in physically ac-
tive individuals have mainly focused on verifying changes
in the state of nutrition, assessing protein synthesis and
proteolysis rates, and monitoring hormone levels and
selected indices illustrating, for example, the degree of
muscle damage and determination of changes in physical
capacity [3, 19–22]. Since 1996, studies have been pub-
lished that claim that HMB uptake may promote advan-
tageous changes in body composition and strength, and
reduced levels of muscle damage markers during resist-
ance training [3, 18, 22, 23]. Further, in a meta-analysis
by Nissen and Sharp [21], it was found that HMB
supplementation for resistance exercise resulted in in-
creased strength and fat-free mass by (net value) 1.4 and
0.28 % per week, respectively, in both trained and un-
trained individuals.
In contrast, the effect of HMB uptake on physical cap-
acity has rarely been verified in endurance sports. HMB-
supplemented cyclists and runners showed an increase in
aerobic adaptation, which was assessed by maximal oxygen
uptake ( _VO2 max), ventilatory threshold (VT), peak oxy-
gen uptake ( _VO2peak), time needed to reach _VO2peak, a
delay in the onset of blood lactate accumulation (OBLA),
and a lower activity of creatine kinase (CK) and lactate
dehydrogenase (LDH) [20, 24–26].
However, it’s important to observe that certain studies
did not show the effectiveness of HMB in enhancing
aerobic capacity [3, 20]. A lack of evidence for the effective-
ness of HMB supplementation on changes in body com-
position, activity of muscle damage markers, or in hormone
concentrations was also presented in studies on participants
involved in resistance or volleyball training [3, 27–29].
In view of the inconclusive character of the study re-
sults conducted to date, and the relatively low number
of studies investigating the effectiveness of HMB over a
longer period on endurance trained athletes, the aim of
this study was to verify the effect of HMB supplementa-
tion on physical capacity, body composition and the




The characteristics of the examined group of athletes are
given in Table 1. The experiment involved 16 elite male
rowers, aged 20 ± 2 years, with a body weight of 87.3 ±
9.8 kg and a height of 187 ± 5 cm. Athletes were members
of the Polish National Team in Rowing and/or rowers
occupying high positions in national competitions. The
criteria for qualifying for the study included, among
others, a good state of health, a valid and current medical
certificate confirming their ability to practice sports, at
least 5 years of training experience, and a minimum of five
rowing training sessions per week. The investigations were
conducted from 2009 to 2014 at different times of the
year. All athletes declared that they had not undergone
Table 1 Characteristics of the participating rowers (n = 16)
Study group
Parameter Means ± SD Range
Age (yr) 19.5 ± 1.4 17.0 – 22.0
Body mass (kg) 87.3 ± 9.8 69.0 – 104.7
Height (cm) 187 ± 5 176 – 194
FFM (kg) 73.8 ± 6.4 63.9 – 83.4
FM (kg) 13.6 ± 5.3 5.1 –21.6
_VO2 max (mL · min
−1 · kg−1) 68.1 ± 6.4 58.4 – 75.0
Peak power (W · kg−1) 11.6 ± 1.1 9.9 – 13.2
Years training (yr) 8.2 ± 2.8 6 – 10
Number of training sessions per week
(session · week−1)
8.6 ± 2.7 7 – 10
Number of hours of training per week
(h · week−1)
16.8 ± 5.9 10 – 24
Energy intake (kcal · kg−1 · day−1)a 56.1 ± 14.2 37.0 – 79.2
Protein intake (g · kg−1 · day−1)a 1.6 ± 0.2 1.3 – 2.0
Carbohydrate intake (g · kg−1 · day−1)a 6.3 ± 1.4 4.9 – 9.3
Fat intake (g · kg−1 · day−1)a 1.7 ± 0.4 1.2 – 2.4
FFM fat-free mass, FM fat mass; _VO2max maximal oxygen uptake
aMean energy and macronutrient intake during the supplementation period
Durkalec-Michalski and Jeszka Journal of the International Society of Sports Nutrition  (2015) 12:31 Page 2 of 11
changes in their lifestyle, characteristics of training, nutri-
tion, or supplementation, and that they were not using
any preparations with potential ergogenic effects, other
than those supplied by the authors of this study. More-
over, dietary journals were performed every second week,
which proved that athletes did not change their dietary
habits during the supplementation period.
In accordance with the Declaration of Helsinki, all the
participants expressed their free and conscious consent to
participate in the research procedures. The consent of the
Bioethics Committee at Poznań University of Medicine
Sciences was obtained for this study (decision no. 584/09
of 18 June 2009).
Experimental design
Characteristics of the administered supplementation
The effect of HMB supplementation was assessed in
randomised, crossover, double-blind tests (Fig. 1). The
experimental procedure for each athlete included a 12-
week supplementation with an HMB preparation and a
12-week placebo administration. Upon determining ex-
periment qualification, the athletes were subjected to the
randomisation procedure (based upon lean body mass)
and assigned either to the group receiving the HMB
preparation in the first 12 weeks of the trial or to the
group receiving the placebo. After 12 weeks, a 10-day
washout period was implemented, which was similar in
other studies and sufficient given the kinetics of HMB
absorption and excretion from the body [24, 30, 31].
After the washout period, a crossover exchange of the
preparations administered to the groups was applied.
The experiments were conducted using a preparation
of calcium salt of HMB produced by Olimp Laborator-
ies. A single capsule contained 1250 mg of Ca-HMB,
which corresponds to 1000 mg HMB. The producer also
prepared a placebo preparation containing maltodextrin.
The tested group of athletes was administered three cap-
sules of the assigned preparation per day in three doses
as follows: upon waking, immediately after training, and
before sleep. On non-training days, the participants were
instructed to consume one serving with each meal
throughout the day. The consumed HMB dose was
equivalent to the most commonly recommended intake
of 3 g HMB per day [2, 3, 5, 19, 26].
Among all participants, the efficacy of HMB supple-
mentation was assessed using four series of research
(each included: evaluation of body composition, aerobic
and anaerobic capacity, as well as blood sampling and
biochemical analyses), consisting of identical procedures
in two cycles separated by a washout period: the tests
took place prior to the onset of the intervention (PreHMB
and PrePLA), following the 12 weeks of supplementation
with the HMB preparation (PostHMB) and the placebo
(PostPLA). As mentioned in the methods section, all
athletes declared that they had not undergone changes
in their lifestyle, characteristics of training, or nutrition.
Evaluation of body mass and composition
Body weight and height were measured using a WPT
60/150 OW medical anthropometer by RADWAG®
(Poland). Body composition was analysed by determining
the values of electrical resistance and reactance through
bioelectric impedance with the use of a BIA 101S ana-
lyser by AKERN-RJL (Italy) and the Bodygram 1.31 com-
puter software by AKERN-RJL (Italy). Body composition
was measured strictly following the recommended meas-
urement conditions, i.e. in the morning hours, following
overnight fasting, in subjects lying in a supine position,
and with the recommended application of measuring
electrodes [32]. Athletes were also instructed to abstain
Fig. 1 A flow chart of the study design
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from drinking coffee, strong tea, caffeine-containing
products, and alcohol for at least 24 h before the test, as
well as to refrain from physical exercise for a minimum
of 18 h before measurements.
Assessment of aerobic capacity
The exercise tests to assess the selected capacity parameters
in the athletes were conducted in the morning hours (be-
tween 7:00 and 10:30 a.m.), always in the same conditions
(temperature of 20–22 °C, relative humidity of 50–60 %) at
the Exercise Tests Laboratory at the Department of Human
Nutrition and Hygiene, Poznań University of Life Sciences.
Prior to each test, the athletes were informed, in detail, of
the objective, procedure and methods of the exercise tests.
The level of aerobic capacity in athletes was assessed based
on the recorded maximal oxygen uptake ( _VO2 max ) and
the VT during a test that involved performing exercise with
increasing intensity (+50 W each 3 min) on a Kettler X1
cycloergometer (Kettler, Germany), following recommenda-
tions for such tests [33]. During the tests, the respiration in-
dices were recorded using a portable K4b2 ergospirometer
(Cosmed, Italy) and the COSMED CPET Software Suite
(ver. 9.1b, 2010). Moreover, the Cosmed K4b2 system was
calibrated prior to each individual test according to the
manufacturer’s guidelines.
In this study, maximal exercise was assumed to occur
when an increase in load failed to produce an increase
in oxygen uptake ( _VO2) and heart rate (HR). In order to
determine the VT, the V-slope method was applied
based on an analysis of linear regression for the curve of
increasing CO2 exhalation in relation to the curve of
increasing O2 uptake [34].
Blood sampling and biochemical analyses
The most widely used markers of adaptation and homeo-
stasis in studies involving athletes were applied in this
investigation. The activity of the CK and LDH enzymes,
and the concentration of testosterone and cortisol (for
calculating the T/C ratio) were assessed based on a quan-
titative analysis of the blood plasma of the athletes using
commercial diagnostic tests. Twenty to twenty-five mi-
nutes after the exercise test, blood samples were collected
from the athletes from the ulnar vein to two closed-
system evacuated test tubes of 2.7 mL, using lithium
heparine and sodium fluoride as anticoagulants (Sarstedt
Monovette®, Germany). The collected plasma was sub-
jected to further laboratory analyses on the same day. CK
and LDH activity were assayed using a standardised
colorimetric enzymatic method with a COBAS® 6000
analyser (module c 501, Roche/Hitachi, USA). The con-
centrations of testosterone and cortisol in blood plasma
were assayed by ECLIA electrochemiluminescence using a
COBAS® 6000 analyser (module e 601, Roche/Hitachi,
USA).
Assessment of anaerobic capacity
Anaerobic capacity was assessed using the classical
Wingate test on a cycloergometer (Monark 894E, Sweden)
following recommendations for such tests proposed by
Bar-Or [35]. Seat height was adjusted to each participant’s
satisfaction, and toe clips with straps were used to prevent
the feet from slipping off the pedals. The primary test was
preceded by a 5-min warm-up period of approximately
50 W power, followed by a 5-min break. This was followed
by two run-up practices of 3 s, during which the actual
test load was imposed to accustom the participants to the
resistance. The test lasted for 30 s. External loading was
estimated individually at 7.5 % body weight. During the
test, the athletes were encouraged to maintain maximum
effort. Recorded results included the peak power output
(PP), the average power output (AP), and the mean power
output (MP), which were analysed using Monark Anaer-
obic Test Software (ver. 3.0.1, 2009, Sweden). The fa-
miliarization session for subjects was not needed, because
the rowers were quite familiar the Wingate test, due to
previous studies and training procedure.
Statistical analysis
All statistical calculations were performed using the Statis-
tica 10.0 package (StatSoft, Poland, 2011). Sample size was
determined using previously published data [25, 26]. Basic
descriptive statistics were calculated for the tested parame-
ters, and the results are presented as means and standard
deviations (± SD) for at least four independent series of
measurements. The Shapiro-Wilk test was applied in order
to determine whether the random sample came from a
population with a normal distribution. The statistical ana-
lysis was performed based on the research hypothesis that
the HMB supplementation support the physical capacity
and body composition regulation in trained athletes.
Therefore statistical tests were selected in order to com-
pare the significance of the changes resulting from the
HMB supplementation or placebo. Since a crossover de-
sign was used in this study and all subjects received both
HMB and placebo. The significance of the differences in
the mean value of parameters between HMB and placebo
were tested using independent samples t-tests in the case
of normally distributed variables, or by Mann–Whitney U
tests in the case of non-normally distributed variables.
Differences in mean values of parameters between base-
line (Pre) and post-intervention (Post) were tested by
dependent samples t-tests (normally distributed variables)
or Wilcoxon-signed rank tests (non-normally distributed
variables).
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Results
Body composition
Following the 12-week HMB supplementation, a significant
decrease (p = 0.03) was recorded in fat mass (−0.9 kgHMB),
while after the placebo treatment this tissue component
increase (+0.8 kgPLA) (Fig. 2). Moreover, in both groups,
weight loss was observed, although there were no differ-
ences between the HMB and placebo. In relation to the
pre-investigation value, after HMB supplementation, the
changes in body mass were significant (p = 0.016), but were
associated with a slight (p = 0.12) reduction in lean body
mass, which significantly decreased by 2.1 kg (p = 0.001)
after the placebo treatment (Table 2).
Maximal oxygen uptake ( _VO2 max)
The analysis of the aerobic capacity indices showed
an increase (p = 0.03) in _VO2 max following the
12 weeks of supplementation with the HMB preparation
(+2.7 mL min−1 · kg−1) in comparison to the reduction of
aerobic capacity following the placebo treatment (−1.0 mL ·
min−1 · kg−1) (Fig. 3). Moreover, in relation to the pre-
investigation value, after the HMB supplementation, a
significant increase was recorded in _VO2 max (p = 0.03)
and exercise time (+1.4 minHMB, p = 0.04) and maximal
load of cycloergometer (+0.38 W · kg−1HMB, p = 0.04),
before the athlete refused to continue the test.
Ventilatory threshold
Analysis of the changes in the recorded markers shows
that, following HMB supplementation, time to reach VT
(TVT: +1.2 minHMB vs. −0.2 minPLA, p = 0.012), relative
threshold load at VT (WVT: +0.42 W · kg
−1
HMB vs.
−0.06 W · kg−1PLA, p = 0.002), and the threshold HR at VT
(HRVT: +9 bpmHMB vs. +1 bpmPLA, p < 0.001) (Fig. 3)
increased significantly. In addition, in comparison to the
pre-investigation value after the HMB treatment, a sig-
nificant increase was recorded in TVT (p = 0.003), WVT
(p < 0.001) and HRVT (p < 0.001) (Table 2).
Biochemical blood markers
Thus was no statistically significant differences between
the HMB and placebo groups in the tested biochemical
markers in the blood. In relation to the initial concentra-
tion of the markers assessed, in both groups, significant
decreases were recorded in CK activity (CKPOST-HMB-
CKPRE-HMB: −87 U · L
−1, p = 0.004; CKPOST-PLA-CKPRE-PLA:
−83 U · L−1, p = 0.008) and LDH activity (LDHPOST-HMB-
LDHPRE-HMB: −15 U · L
−1, p = 0.033; LDHPOST-PLA-
LDHPRE-PLA: −24 U · L
−1, p = 0.002) after the exercise test
with increasing intensity (Table 2).
Anaerobic capacity
Comparing HMB supplementation to the placebo, no sig-
nificant differences were observed in the changes in the
anaerobic power indices during the Wingate test. However,
the analysis of the peak power output showed an increase
(p = 0.02) following the 12 weeks of supplementation with
the HMB preparation (+0.61 W · kg−1) in comparison to
the pre-HMB period (Table 2).
Discussion
The findings in this study indicate that a 12-week HMB
supplementation in athletes practicing endurance sports
Fig. 2 Changes in fat mass after 12-week supplementation of HMB. Values are expressed as mean ± SD. Significant differences compared with
placebo (independent samples t-tests) at: * p = 0.03
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Table 2 Levels of the monitored indices before and after the 12-week supplementation with HMB preparation and placebo
Research period PREHMB vs. PLA HMB Difference PLACEBO Difference
p valuea p valueb p valueb
BM (kg) Pre 0.925 86.5 ± 9.3 0.016 86.2 ± 9.0 0.063
Post 84.6 ± 8.1 84.8 ± 8.5
FFM (kg) Pre 0.921 72.7 ± 6.3 0.117 72.9 ± 6.1 0.001
Post 71.7 ± 5.6 70.9 ± 5.7
FM (kg) Pre 0.755 13.8 ± 4.4 0.073 13.3 ± 4.7 0.197
Post 12.8 ± 4.0 14.1 ± 4.3
_VO2 max (mL · min
−1) Pre 0.681 5794 ± 676 0.240 5897 ± 735 0.067
Post 5905 ± 709 5723 ± 745
_VO2 max (mL · min
−1 · kg−1) Pre 0.572 67.3 ± 6.9 0.033 68.8 ± 8.0 0.438
Post 70.0 ± 6.9 67.8 ± 8.5
Tref (min) Pre 0.947 17.6 ± 3.1 0.043 17.7 ± 3.1 0.233
Post 19.0 ± 3.6 18.5 ± 3.7
Wmax (W) Pre 0.777 372 ± 52 0.052 378 ± 52 0.625
Post 397 ± 56 384 ± 60
Wmax (W · kg−1) Pre 0.621 4.31 ± 0.50 0.039 4.39 ± 0.41 0.234
Post 4.70 ± 0.55 4.55 ± 0.65
HRmax (bpm) Pre 0.962 185 ± 13 0.258 185 ± 9 0.136
Post 188 ± 9 188 ± 10
TVT (min) Pre 0.440 12.5 ± 2.1 0.003 12.8 ± 1.9 0.619
Post 13.7 ± 2.2 12.6 ± 2.6
WVT (W) Pre 0.187 278 ± 41 0.012 294 ± 36 0.310
Post 309 ± 42 284 ± 47
WVT (W · kg
−1) Pre 0.248 3.24 ± 0.51 0.001 3.42 ± 0.32 0.554
Post 3.66 ± 0.36 3.36 ± 0.49
HRVT (bpm) Pre 0.399 157 ± 9 0.001 160 ± 10 0.598
Post 166 ± 11 161 ± 9
CK (U · L−1) Pre 0.865 328 ± 160 0.004 348 ± 169 0.008
Post 241 ± 103 265 ± 156
LDH (U · L−1) Pre 0.573 318 ± 36 0.033 326 ± 45 0.002
Post 302 ± 35 302 ± 39
Testosterone (mg · dL−1) Pre 0.895 510 ± 202 0.352 510 ± 154 0.569
Post 552 ± 160 487 ± 160
Cortisol (mg · dL−1) Pre 0.585 19.9 ± 5.3 0.331 20.0 ± 5.9 0.516
Post 20.6 ± 5.8 20.8 ± 4.1
T/C ratio (T · C−1*10−2) Pre 0.51 3.39 ± 1.77 0.53 3.36 ± 0.99 0.30
Post 3.41 ± 1.08 3.03 ± 1.11
Peak power (W) Pre 0.615 1003 ± 125 0.027 1028 ± 147 0.853
Post 1054 ± 116 1024 ± 122
Peak power (W · kg−1) Pre 0.488 11.65 ± 1.01 0.020 11.92 ± 1.16 0.960
Post 12.26 ± 0.83 11.91 ± 1.15
Average power (W) Pre 0.924 725 ± 87 0.648 722 ± 87 0.660
Post 720 ± 83 718 ± 82
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influences a reduction of fat mass (p = 0.03). Despite the
observed lack of differences in the diets of rowers in the
course of the experimental procedure, changes in body
weight found in both periods were probably caused by a
low energy intake, witch concern only some athletes. It
may have resulted from the insufficient coverage of
high-energy expenditure connected with rowing train-
ing. As mentioned in the methodological part, dietary
recordings were performed every second week, during
the whole study, which proved that athletes did not
change their dietary habits during the HMB supple-
mentation and placebo period. Furthermore the po-
tential impact energy intake is significantly reduced by
randomised crossover design of the study. Thus, the
observed effect of HMB seems considerable, since a
reduction of body weight in supplemented athletes
was connected with not significant reduction of FM
and FFM, while in placebo group FFM reduction was
statistically significant (p = 0.001). Additionally, despite
the supreme importance of aerobic capacity in endur-
ance sports, a significant role may also be played by a
high level of anaerobic adaptation, particularly at the
start or finish of the race [36, 37]. In this study, in rela-
tion to the initial values, only after HMB supplementa-
tion was an increase observed in peak power (p = 0.02).
In turn, in relation to placebo administration after HMB
Table 2 Levels of the monitored indices before and after the 12-week supplementation with HMB preparation and placebo
(Continued)
Average power (W · kg−1) Pre 0.854 8.36 ± 0.60 0.688 8.32 ± 0.55 0.736
Post 8.30 ± 0.59 8.28 ± 0.65
Minimal power (W) Pre 0.478 503 ± 75 0.095 486 ± 52 0.763
Post 475 ± 54 491 ± 78
Minimal power (W · kg−1) Pre 0.465 5.80 ± 0.78 0.119 5.63 ± 0.55 0.821
Post 5.49 ± 0.53 5.67 ± 0.76
Values are expressed as mean ± SD
BM body mass, FFM fat-free mass, FM fat mass, _VO2max maximal oxygen uptake, Tref exercise time before athlete’s refusal to continue exercising, Wmax maximum
load, HRmax maximum heart rate, VT ventilatory threshold, TVT time to VT, WVT load at VT, HRVT heart rate at VT, CK creatine kinase, LDH lactate dehydrogenase,
T/C ratio testosterone/cortisol ratio
aDepending on the data distribution: independent samples t-tests or Mann–Whitney U tests
bDepending on the data distribution: dependent samples t-tests or Wilcoxon-signed rank tests
Fig. 3 Changes in maximal oxygen uptake and rates at ventilatory threshold after 12-week supplementation of HMB. Values are expressed as
mean ± SD. Significant differences compared with placebo (independent samples t-tests) at: *- p = 0.03; †- p = 0.012, ‡- p = 0.002; #- p < 0.001.
_VO2 max: maximal oxygen uptake; TVT: time to VT; WVT: load at VT; HRVT: HR at VT
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intake, advantageous trends were observed indicating an
increase in PP (p = 0.06). No differences were found in
the case of the other indices of anaerobic capacity of
rowers.
However, we would like to highlight here that the
aim of the training regime in the investigated group of
athletes was not to change body composition or anaer-
obic adaptation, but to increase their training poten-
tial. Probably for this reason, changes in fat-free body
mass and power were less important, connected not
only with the assumed negative energy balance (sug-
gested by the reduced body weight of athletes), but
particularly with the lack of an adequate exercise
stimulus for the synthesis of muscle proteins. This may
suggest a limited role of HMB, as postulated in the lit-
erature, in the activation of, for example, mTOR kinase
pathways [6, 8, 12, 13], expression of insulin-like
growth factor-1 (IGF-1) [11, 12], or the reduction of
activity of the ubiquitin-proteasome system and cas-
pase activity [9, 14–16]. This thesis may be confirmed
by the studies, in which individuals supplemented with
HMB performed only resistance exercise, stimulating
(to a greater extent) an increase in fat-free body mass,
which was reported, for example, by Nissen et al. [2]
(FFM: +1.21 kg3.0gHMB vs. +0.8 kg1.5gHMB vs. +0.4 kgPLA)
and Gallagher et al. [19] (FFM: +1.9 kg). In turn, upon
HMB supplementation in experiments on volleyball
players, in which a key role was played by muscle power,
an increase in FFM (+2.3 kg) was recorded, as well as re-
duction of fat mass by ~0.6 kgFM - comparable to that
found our this study [3]. Moreover, in athletes adminis-
tered the placebo in Portal et al. [3], a slight decrease in
FFM (0.1 kg) and an increase of fat mass (3.6 % FM) was
found. Furthermore, with an increase in FFM in
volleyball players, an increase was recorded in peak
(1.7 W · kg−1HMB vs. 0.4 W · kg
−1
PLA) and average power
(0.9 W · kg−1HMB vs. 0.1 W · kg
−1
PLA). These observations
may be confirmed by a study by Molinari et al. [38], who
recorded increased muscle power (9.2 % HMB vs. 1.7 %
PLA) in volleyball players using HMB. In turn, in a study
on judoists subjected to a 3-day limitation of energy in-
take (20 kcal · kgbm
−1 day−1) a reduction (p < 0.05) was re-
corded for fat mass (−0.85 % HMB vs. 0.2 % PLA) only in
the group of athletes supplemented with HMB, although
no differences were found in indices of anaerobic power
between athletes using HMB and placebos [23]. Apart
from the negative energy balance, this may have resulted
from the fact that HMB supplementation lasted only
3 days, which seems too short to cause significant
changes in systemic anaerobic potential. HMB impact on
body composition observed also Caperuto et al. [39]. In
rats supplemented with 320 mg · kg−1 body weight of
HMB, carcass fat significantly decreased. Such a large ef-
fect was not observed in our study, which we may
assume could be related to the dose/response concept.
Furthermore, no significant results from the supple-
mented group when compared to placebo might explain
the fact, that HMB supplementation can increase adapta-
tion and promotes metabolic changes in a time-dependent
manner [39]. In turn, in the case of endurance sports,
changes in FM described in this study seem to be ex-
plained by the increase in fatty acid oxidation, as well as
lipolysis and insulin sensitivity (e.g., due to the stimulation
of activation of AMPK kinase, Sirt1 and the dependent
metabolic pathways) [18].
We need to stress here that there is a limited body of
literature assessing the efficacy of HMB intake in endur-
ance sports. In terms of the effect of HMB on body
composition in runners, Knitter et al. [20], Lamboley et
al. [26] and Robinson et al. [25] observed no differences
in body composition in athletes who were administered
HMB or a placebo. Does that mean that HMB has a def-
inite effect on body composition and anaerobic adapta-
tion only in individuals involved in resistance training?
This study was conducted on trained rowers, practicing
(first of all) to increase endurance, although their training
procedure also included periodical resistance exercise. The
recorded results seem to indicate efficacy of HMB supple-
mentation in relation to the advantageous reduction of FM
and a tendency to increase peak power. However, it seems
obvious that the efficacy of HMB in stimulating an increase
in FFM and anaerobic capacity may be observed particu-
larly in the case of incorporation of resistance exercise and/
or high-intensity exercise to the training regime, stimulat-
ing, to a greater extent, muscle protein synthesis pathways,
which would enhance the potential anticatabolic role of
HMB.
When assessing the effect of HMB supplementation in
endurance sports, the effect of this preparation on aerobic
adaptation seems to play a key role. Vukovich and Dreifort
[24], after a 2-week HMB supplementation in cyclists,
recorded an increase (p < 0.05) in peak oxygen uptake
( _VO2peak) by 4 % and an extension of the time required
to reach _VO2peak by 3.6 %. Moreover, values of these in-
dices increased (p < 0.05) also in comparison to the results
recorded in groups administered leucine or a placebo.
Similar results were observed in this study, in which
_VO2 max of rowers increased after 12-week HMB sup-
plementation, both in relation to the placebo treatment
and values before its supplementation (PreHMB). In the
study by Vukovich and Dreifort cited above, the ad-
ministration of HMB also led to an advantageous in-
crease in the lactate threshold, which, when expressed
in percent _VO2peak, increased by 8.6 %. Also found
was a delayed OBLA observed at the oxygen uptake,
which increased by 9.1 %. Thus, these results seem to
confirm the effect of HMB supplementation observed
in this study on the increase in aerobic adaptation of
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athletes. Furthermore, these observations correspond also
to the latest results reported by Robinson et al. [25], who,
in a group of males and females after a 4-week HMB
supplementation, combined with high-intensity interval
training, found levels of _VO2peak higher by almost 5.9 %
(p = 0.032) and 9.8 % (p < 0.001), respectively, in compari-
son to the placebo and the control groups. The authors
also found VT to be higher by almost 9.3 % (p = 0.017)
and 16.5 % (p = 0.012), respectively. Another important
point showed Lamboley et al. [26], in the previously
described study, also showed an advantageous effect of
HMB supplementation resulting from the considerable
increase in _VO2 max by as much as 7.7 ml · kg
−1 · min−1.
In both groups, a significant improvement was also
found in VT (+11.1 % HMB vs. +9.0 % PLA). Despite the
increase in _VO2 max values recorded in this study in
the group supplemented with HMB, the differences
were not high, which suggests that they may have re-
sulted, to a considerable degree, from the fact that
participants in this study practiced sports as recreation
and, prior to the onset of the experimental procedure,
had no aerobic training. In contrast, this study involved
elite rowers and, even a slight increase in aerobic cap-
acity in their case, may be considered to be particularly
advantageous.
Thus when considering the results of this study, litera-
ture data as well as the above mentioned potential
mechanisms of HMB action, connected (for example)
with the regulation of muscle protein expression, main-
tenance of cell wall integrity or stimulation of activity of
AMPK kinase and Sirt 1, which promotes stimulation of
mitochondrial biogenesis, higher oxygen consumption
and increased efficiency of carbohydrate, glycogen and
fat metabolism [17, 18, 39, 40], it may be inferred that
HMB supplementation under specific conditions seems
to also enhance the increase in aerobic capacity. Increas-
ing the usability and availability of energy substrates thus
appears to explain the growth of aerobic adaptation
(VO2max, VT) of rowers. Observed after HMB supple-
mentation physical capacity increase, could be in practice
due to the more efficient use of exercise stimulus, as well
as increase the efficiency of post-exercise recovery period,
which are necessary to achieve super compensation.
It turns out that HMB supplementation applied in this
study had no effect on the levels of blood biochemical
markers. Literature data also did not clearly show the ef-
fect of HMB on changes in their concentrations. Nissen
et al. [2] and van Someren et al. [22], following HMB
supplementation, found a lower activity of CK and/or
LDH in the blood of examined individuals. The above ob-
servations seem to suggest that HMB supplementation
may play a significant role in the reduced rate of muscle
damage. However, long-term HMB supplementation in
trained individuals, e.g. as a result of homeostatic mecha-
nisms in the organism, may reduce the effects of this sub-
stance on the level of adaptation of the organism verified
by the analyses of levels of standard biochemical markers
in the blood. To confirm this thesis, Gallagher et al. [19],
in a group receiving HMB, showed a lower CK activity
(by approximately 200 U · kg−1) 48 h after a series of
resistance exercises; however, this effect disappeared after
a longer supplementation period. In turn, in runners,
Knitter et al. [20] observed lower concentrations of CK
and LDH in a group supplemented with HMB immedi-
ately after they completed a 20 km race, as well as during
the three successive days after this exercise. Thus, the
cited studies seem to confirm the hypothesis on the effect
of HMB on the stimulation of sarcolemma integrity and
inhibition of proteolytic activity of the ubiquitin-
proteasome system. This may indicate the advisability of
HMB supplementation in sports due to the reduced rate
of muscle damage as a consequence of intensive exercise
loads.
It’s important to observe that a limited number of stud-
ies analysed the effect of HMB uptake on the systemic
hormone metabolism. In comparison to the resting-state
hormone concentrations recorded prior to the tests and
following 12 weeks of HMB administration combined
with power training, Kreamer et al. [41] showed a signifi-
cant increase in the pre-exercise concentration of testos-
terone and a reduction of cortisol levels, which were not
observed in the control. In supplemented group 15 min
after the completion of exercise, blood testosterone con-
centration increased considerably, but after 30 min, the
level of this hormone was similar to that recorded in the
control group. No significant differences were observed
in the blood concentrations of cortisol, although in this
supplemented group a reduced level 30 min after exercise
was found. In a recent paper of Townsend et al. [42] tes-
tosterone levels significant increased immediately after
exercise in comparison to baseline, but also returned
after 30 min, in resistance trained men, supplemented
with HMB. This finding might explain no significant
results observed in this study. Seems to be possible that
HMB supplementation can promotes hormonal
changes observed in a time-dependent manner.
We would like to highlight here that numerous studies
are consistent with the results of this study and do not
confirm the effect of HMB, in comparison to placebo, on
activity of CK and LDH [19, 27–29, 43] or blood testoster-
one concentration [3, 27, 28]. We need to mention here
that when assessing levels of biochemical markers following
supplementation, it is difficult to reliably compare the
presented studies. The final results may have been affected
not only by the dose of the preparation, but also by the
duration of supplementation, the training standard of ath-
letes involved in the experiment and applied training loads.
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Conclusions
This study indicates that HMB supplementation in athletes
training for endurance sports promotes the advantageous
increase in aerobic capacity of the organism, mainly due to
the increased values of maximum oxygen uptake and indi-
ces of the VT, as well as the reduction of fat mass. It may
also enhance peak anaerobic power. Long-term HMB
supplementation seems not only to have a significant effect
on changes in activity of selected intramuscular enzymes
testosterone and cortisol concentration, but also on values
of the T/C ratio in blood.
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